PORTAGE BIOTECH
Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization. Portage is seeking discovery and co-development partners in areas such as cancer, infectious disease, neurology and psychiatry developing novel targeted therapies, stem cell therapy and even older marketed products that have been found to have novel patentable characteristics that bring new value to patients.
PORTAGE BIOTECH
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
1973-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.portagebiotech.com
Total Employee:
1+
Status:
Active
Contact:
(416) 929-1806
Total Funding:
50.64 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-06 | Tarus Therapeutics | Tarus Therapeutics acquired by Portage Biotech | 21 M USD |
| 2018-08-14 | SalvaRx Ltd. | SalvaRx Ltd. acquired by Portage Biotech | 71.7 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-11 | Stimunity | Portage Biotech investment in Seed Round - Stimunity | 900 K EUR |
| 2019-03-25 | Stimunity | Portage Biotech investment in Seed Round - Stimunity | 600 K EUR |
| 2018-03-08 | iOx Therapeutics Ltd. | Portage Biotech investment in Convertible Note - iOx Therapeutics Ltd. | 950 K USD |
| 2018-03-01 | Stimunity | Portage Biotech investment in Seed Round - Stimunity | 2 M EUR |
Official Site Inspections
http://www.portagebiotech.com Semrush global rank: 4.43 M Semrush visits lastest month: 2.18 K
- Host name: 133.191.196.104.bc.googleusercontent.com
- IP address: 104.196.191.133
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Portage Biotech"
about us - Portage Biotech
Robert Kramer, PhD Chief Scientific Officer. Robert has 24 years of experience in the pharmaceutical industry and is the former Head of Oncology Discovery Research at both …See details»
Corporate Governance - Portage Biotech
Country of Incorporation and Registered Office: The Company is domiciled on the British Virgin Islands and has a registered office and billing address at FH Corporate Services Ltd., of FH …See details»
Portage Biotech - Crunchbase Company Profile
Portage Biotech is a pharmaceutical company that identifies and develops best-in-class or first-in-class early-to-mid stage products.See details»
News Release Details - ir.portagebiotech.com
Dec 31, 2021 “With our enhanced management team, efficient organization, and financial resources obtained in 2021, we are well positioned to execute our unique drug development …See details»
Portage Biotech Inc - LinkedIn
Portage Biotech is clinical stage biopharmaceutical company driving the development of first-in-class immuno-oncology therapies to help more patients achieve durable treatment responses …See details»
News Release Details - ir.portagebiotech.com
For more information, please visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking Statements …See details»
Portage Biotech Company Profile - Office Locations, Competitors …
Apr 12, 2021 See insights on Portage Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Portage Biotech Reports Business and Strategic Update - Yahoo …
Jan 4, 2024 Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, …See details»
News Release Details - Portage Biotech
Mar 31, 2023 For more information, please visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking Statements …See details»
Portage Biotech Announces Plans to Expand its Evaluation of …
Apr 12, 2024 -Adenosine clinical development pausedWESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno …See details»
PORTAGE BIOTECH INC.
Mar 31, 2022 visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking Statements This news release contains …See details»
Portage Biotech Provides Research and Development Update
Sep 14, 2022 Portage Biotech, Inc.--The Company Highlights its Clinical Strategy for its Adenosine and iNKT Platforms----Clinical Development Goals are Focused on Producing …See details»
Portage Biotech Provides Research and Development Update
Sep 14, 2022 For more information, please visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking StatementsSee details»
our pipeline - Portage Biotech
Additional Programs in Development . Portage’s pipeline also includes antibodies, small molecules and protein therapeutics delivered by novel intratumoral formulations (PORT-1), …See details»
News Release Details - ir.portagebiotech.com
Jul 20, 2022 For more information, please visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking Statements …See details»
News Release Details - ir.portagebiotech.com
Jun 6, 2022 For more information, please visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech, or find us on LinkedIn at Portage Biotech Inc. About Intensity Therapeutics …See details»
News Release Details - Portage Biotech
Nov 6, 2023 For more information, please visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking Statements …See details»
NEWS RELEASE PORTAGE COMMENCES TRADING ON NASDAQ
Feb 25, 2021 To learn more about Portage, please visit www.portagebiotech.com About Portage Biotech Inc. Portage is a clinical stage immuno-oncology company advancing first-in-class …See details»
PORT-4 – Nanolipogel Formulations - Portage Biotech
Portage Biotech Inc. Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 203.221.7378 [email protected]See details»